diagnostics

Premium

Healthcare

24 December, 2019

Flashback 2019: Single-specialty, regional hospitals steal the thunder in healthcare

A strong revival of investor interest in eye-care clinics, big-ticket deals in the dialysis, fertility and oncology segments and a ......

Premium

Healthcare

11 October, 2019

Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit

Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying about government moves to ......

Premium

Healthcare

08 April, 2019

Dr Lal PathLabs CEO on acquisition plans and declining PE interest in diagnostics

Dr Lal PathLabs Ltd, which became the first Indian diagnostics chain to list on the stock exchanges in 2015, has ......

Premium

Healthcare

29 March, 2019

Value Lens: How does Metropolis Healthcare size up against listed peers?

When Metropolis Healthcare Ltd goes public next week, it will become the third diagnostics chain to launch an initial public ......

Premium

Healthcare

28 March, 2019

Tracing Carlyle's returns from partial exit in Metropolis' upcoming IPO

US-headquartered private equity giant The Carlyle Group appears likely to score modest returns from the sale of a little more ......

Premium

Healthcare

03 December, 2018

Eight Roads-backed Core Diagnostics scouts for tie-ups, M&As for expansion

Core Diagnostics Pvt. Ltd has been stitching a slew of partnerships to boost its main high-end oncology diagnostics test platform ......

Premium

Healthcare

16 November, 2018

Diagnostics firms should still get fair valuation in IPOs: Thyrocare's Velumani

Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have ......

Premium

Healthcare

13 November, 2018

PE funding isn't on GSK Velu's mind as he charts course for Neuberg Diagnostics

A year after re-entering the diagnostics business, serial entrepreneur GSK Velu is looking to steer his newest venture through its ......

Premium

TMT

09 November, 2018

Impact investor Acumen injects more money into health-tech firm Healthcubed

Impact investor Acumen has put more money into diagnostics-focussed health-tech startup Healthcubed Inc, executives at the early-stage investment firm told ......

Premium

Healthcare

17 October, 2018

Suburban Diagnostics to draw up exit plan for early investor Sequoia

Mumbai-based pathology chain Suburban Diagnostics India Pvt. Ltd will continue to explore inorganic growth opportunities while also firming up plans ......